[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339051-105":59,"doc-detail-339051-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multi-omics-analysis-reveals-the-ifi6-gene-as-a-prognostic-indicator-and-therapeutic-target-in-esophageal-cancer","Multi-Omics Analysis Reveals the IFI6 Gene as a Prognostic Indicator and Therapeutic Target in Esophageal Cancer","","The study investigates the IFI6 gene to clarify its role in esophageal cancer (ESCA) and to discover prognostic and targeted-therapy opportunities. Using public cohorts from GEO and TCGA, it evaluates IFI6 expression, epigenetic-related mechanisms, and signaling activities, and relates findings to clinical features and immune-cell correlations. Pan-cancer and subgroup patterns are assessed with TIMER2.0 and UALCAN, pathway associations with KEGG, and immune-functional links with GO enrichment. Results show IFI6 overexpression, strong immune associations, and pathway enrichment in interferon and cytosolic DNA sensing, supporting IFI6 as a biomarker and therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-analysis-reveals-the-ifi6-gene-as-a-prognostic-indicator-and-therapeutic-target-in-esophageal-cancer/339051/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-analysis-reveals-the-ifi6-gene-as-a-prognostic-indicator-and-therapeutic-target-in-esophageal-cancer/339051.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study?","Question",{"text":112,"@type":113},"To determine whether IFI6 can serve as a prognostic indicator and a therapeutic target in esophageal cancer by examining its expression, mechanisms, and pathway and immune associations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which public resources and analysis tools were used?",{"text":117,"@type":113},"The study uses GEO and TCGA for analyses, TIMER2.0 for pan-cancer expression, UALCAN for tumor stage and histology patterns, and KEGG/GO for pathway and biological process enrichment.",{"name":119,"@type":110,"acceptedAnswer":120},"What immune-related associations were reported for IFI6?",{"text":121,"@type":113},"IFI6 expression correlates with CD4+ T cells and B cell receptor (BCR) features, and enrichment points to immune defense functions linked to interferon signaling and viral-response pathways.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339051,1790193293,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Article  \nMulti-Omics Analysis Reveals the IFI6 Gene as a Prognostic Indicator and Therapeutic Target in Esophageal Cancer  \nNguyen-Kieu Viet-Nhi 1, Tran Minh Quan 2, Vu Cong Truc 3, Tran Anh Bich 4, Pham Hoang Nam 4, Nguyen Quoc Khanh Le 5,6,7,8, Po-Yueh Chen 9,10, *,† and Shih-Han Hung 1,9,10, *,†  \nCitation: Viet-Nhi, N.-K.;  \nMinh Quan, T.; Cong Truc, V.;  \nAnh Bich, T.; Hoang Nam, P.;  \nLe, N.Q.K.; Chen, P.-Y.; Hung, S.-H. Multi-Omics Analysis Reveals the IFI6 Gene as a Prognostic Indicator and Therapeutic Target in Esophageal Cancer. Int. J. Mol. Sci. 2024, 25, 2691 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25052691  \nAcademic Editor: Camelia Quek  \nReceived: 25 January 2024  \nRevised: 20 February 2024  \nAccepted: 23 February 2024  \nPublished: 26 February 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; [d142110002@tmu.edu.tw](d142110002@tmu.edu.tw)  \n2 Department of Thoracic Surgery, Cho Ray Hospital, Ho Chi Minh City 700000, Vietnam; [tranminhquan.yds@gmail.com](tranminhquan.yds@gmail.com)  \n3 Department of Otolaryngology, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam; [trucvucong@gmail.com](trucvucong@gmail.com)  \n4 Department of Otolaryngology, Cho Ray Hospital, Ho Chi Minh City 700000, Vietnam; [trananhbich2015@gmail.com](trananhbich2015@gmail.com) (T.A.B.); [bsnamtmh@gmail.com](bsnamtmh@gmail.com) (P.H.N.)  \n5 Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; [khanhlee@tmu.edu.tw](khanhlee@tmu.edu.tw)  \n6 AIBioMed Research Group, Taipei Medical University, Taipei 110, Taiwan  \n7 Research Center for Artificial Intelligence in Medicine, Taipei Medical University, Taipei 110, Taiwan  \n8 Translational Imaging Research Center, Taipei Medical University Hospital, Taipei 110, Taiwan  \n9 Department of Otolaryngology, Wan Fang Hospital, Taipei Medical University, Taipei 110, Taiwan  \n10 Department of Otolaryngology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan  \n* Correspondence: [110120@w.tmu.edu.tw](110120@w.tmu.edu.tw) (P.-Y.C.); [seedturtle@gmail.com](seedturtle@gmail.com) (S.-H.H.)† These authors contributed equally to this work.  \nAbstract: The role of the IFI6 gene has been described in several cancers, but its involvement in esophageal cancer (ESCA) remains unclear. This study aimed to identify novel prognostic indicators for ESCA-targeted therapy by investigating IFI6’s expression, epigenetic mechanisms, and signaling activities. We utilized public data from the Gene Expression Omnibus (GEO) and the Cancer Genome Atlas (TCGA) to analyze IFI6’s expression, clinical characteristics, gene function, pathways, and correlation with different immune cells in ESCA. The TIMER2.0 database was employed to assess the pan-cancer expression of IFI6, while UALCAN was used to examine its expression across tumor stages and histology subtypes. Additionally, the KEGG database helped identify related pathways. Our findings revealed 95 genes positively correlated and 15 genes negatively correlated with IFI6 in ESCA. IFI6 was over-expressed in ESCA and other cancers, impacting patient survival and showing higher expression in tumor tissues than normal tissues. IFI6 was also correlated with CD4+ T cells and B cell receptors (BCRs), both essential in immune response. GO Biological Process (GO BP) enrichment analysis indicated that IFI6 was primarily associated with the Type I i","cbCaiepAz5cCHPXI","https://ap.wps.com/l/cbCaiepAz5cCHPXI","pdf",19830637,16,"English","# Abstract\n# Introduction\n## Esophageal cancer background and treatment options","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To determine whether IFI6 can serve as a prognostic indicator and a therapeutic target in esophageal cancer by examining its expression, mechanisms, and pathway and immune associations.\"},{\"question\":\"Which public resources and analysis tools were used?\",\"answer\":\"The study uses GEO and TCGA for analyses, TIMER2.0 for pan-cancer expression, UALCAN for tumor stage and histology patterns, and KEGG/GO for pathway and biological process enrichment.\"},{\"question\":\"What immune-related associations were reported for IFI6?\",\"answer\":\"IFI6 expression correlates with CD4+ T cells and B cell receptor (BCR) features, and enrichment points to immune defense functions linked to interferon signaling and viral-response pathways.\"}]","Multi-Omics Analysis Reveals the IFI6 Gene as a Prognostic Indicator and Therapeutic Target in Esophageal Cancer | PDF",1790027533,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfa7df4f9920173ed3af6f05eb1de2ed.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa354016aec8b4ea4e6bf001c27d8f5d.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b1175cef918a9ed82355015e8ed18d5.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b821ef504ee00903224eb2dcd2bf66cf.webp",980,1385]